Covid-19-associated anxiety and depression spectrum disorders in Primary health care

Abstract

Anxiety and depression have an extremely high prevalence in the population, being one of the major health problems worldwide. With the sudden COVID-19 pandemic, the study of anxiety-depressive illness among patients in general medical practice has acquired a greater incidence in the study of this serious medical and social problem. The aim of the study was to identify the level of increased excitability and depression in patients with suspected COVID-19 infection, as well as nosological affiliation to somatic diseases. Using the HADS scale, an anonymous screening examination was carried out on 184 patients who were in outpatient appointments at one of the family policlinics in the Mirzo-Ulugbek district of Tashkent, of which 108 were women and 76 were men. It was found that among patients with clinical manifestations of increased anxiety and depression, cases of the disease are often observed in persons with respiratory diseases. In general, the level of anxiety and depression was found in individuals with a history of a higher previous coronavirus infection. Timely detection and correction of anxiety-depressive disorders most fully compensate for the condition of patients with somatic diseases.